The Effect of Activated Factor VII for Intracerebral Hemorrhage Beyond 3 Hours Versus Within 3 Hours

Recombinant-activated factor VII (rFVIIa) is an investigational treatment for intracerebral hemorrhage (ICH). We have evaluated the drug's treatment effect based on time to treatment. ICH patients treated up to 4 hours from symptom onset were divided based on time to treatment:

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Stroke (1970) 2008-02, Vol.39 (2), p.473-475
Hauptverfasser:	HALLEVI, Hen, GONZALES, Nicole R, SHALTONI, Hashem M, GROTTA, James C, BARRETO, Andrew D, MARTIN-SCHILD, Sheryl, ALBRIGHT, Karen C, NOSER, Elizabeth A, ILLOH, Kachi, KHAJA, Aslam M, ALLISON, Teresa, ESCOBAR, Miguel A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Biological and medical sciences Cerebral Hemorrhage - blood Cerebral Hemorrhage - drug therapy Cerebral Hemorrhage - mortality Cohort Studies Factor VIIa - administration & dosage Factor VIIa - adverse effects Hematoma - blood Hematoma - drug therapy Hematoma - mortality Humans Medical sciences Middle Aged Neurology Neuropharmacology Neurotransmitters. Neurotransmission. Receptors Pharmacology. Drug treatments Serotoninergic system Time Factors Treatment Outcome Vascular diseases and vascular malformations of the nervous system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Recombinant-activated factor VII (rFVIIa) is an investigational treatment for intracerebral hemorrhage (ICH). We have evaluated the drug's treatment effect based on time to treatment. ICH patients treated up to 4 hours from symptom onset were divided based on time to treatment:
ISSN:	0039-2499 1524-4628
DOI:	10.1161/STROKEAHA.107.497651